Hitokazu Esaki

Hitokazu Esaki

Auto-generated profile, based on publicly available information

Hitokazu Esaki

Laboratory for Investigative Dermatology, Rockefeller University, New York, NY; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
HEHitokazu Esaki
Hitokazu Esaki
DEDavid A. Ewald
David A. Ewald
BUBenjamin Ungar
Benjamin Ungar
MRMariya Rozenblit
Mariya Rozenblit
XZXiuzhong Zheng
Xiuzhong Zheng
EGEmma Guttman-Yassky
Emma Guttman-Yassky

1 October 2015 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
TCTali Czarnowicki
Tali Czarnowicki
HEHitokazu Esaki
Hitokazu Esaki
JGJuana Gonzalez
Juana Gonzalez
DMDana Malajian
Dana Malajian
ASAvner Shemer
Avner Shemer
EGEmma Guttman-Yassky
Emma Guttman-Yassky

1 January 2017 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
Amy PallerAmy Paller
Amy Paller
YRYael Renert-Yuval
Yael Renert-Yuval
MSMaria Suprun
Maria Suprun
HEHitokazu Esaki
Hitokazu Esaki
MOMargeaux Oliva
Margeaux Oliva
EGEmma Guttman-Yassky
Emma Guttman-Yassky

1 January 2016 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
TCTali Czarnowicki
Tali Czarnowicki
JGJuana Gonzalez
Juana Gonzalez
KBKathleen M. Bonifacio
Kathleen M. Bonifacio
ASAvner Shemer
Avner Shemer
PXPeng Xiangyu
Peng Xiangyu
EGEmma Guttman-Yassky
Emma Guttman-Yassky

1 July 2017 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
TCTali Czarnowicki
Tali Czarnowicki
HEHitokazu Esaki
Hitokazu Esaki
JGJuana Gonzalez
Juana Gonzalez
YRYael Renert-Yuval
Yael Renert-Yuval
PBPatrick Brunner
Patrick Brunner
Amy PallerAmy Paller
Amy Paller

1 October 2015 in Journal of Medicinal Food
Verified
Journal Article
Closed access
TNTakeshi Nakahara
Takeshi Nakahara
CMChikage Mitoma
Chikage Mitoma
AHAkiko Hashimoto-Hachiya
Akiko Hashimoto-Hachiya
MTMasakazu Takahara
Masakazu Takahara
GTGaku Tsuji
Gaku Tsuji
MFMasutaka Furue
Masutaka Furue
Opuntia ficus-indica (OFI) is a cactus species widely used as an anti-inflammatory, antilipidemic, and hypoglycemic agent. It has been shown that OFI extract (OFIE) inhibits oxidative stress in animal models of diabetes and hepatic disease; however, its antioxidant mechanism remains largely unknown. In this study, we demonstrated that OFIE exhibited potent antioxidant activity through the activation of nuclear factor erythroid 2-related factor 2 (NRF2) and the downstream antioxidant enzyme quinone oxidoreductase 1 (NQO1), which inhibited the generation of reactive oxygen species in keratinocytes challenged with tumor necrosis factor α or benzo[α]pyrene. The antioxidant capacity of OFIE was canceled in NRF2 knockdown keratinocytes. OFIE exerted this NRF2-NQO1 upregulation through activation of the aryl hydrocarbon receptor (AHR). Moreover, the ligation of AHR by OFIE upregulated the expression of epidermal barrier proteins: filaggrin and loricrin. OFIE also prevented TH2 cytokine-mediated downregulation of filaggrin and loricrin expression in an AHR-dependent manner because it was canceled in AHR knockdown keratinocytes. Antioxidant OFIE is a potent activator of AHR-NRF2-NQO1 signaling and may be beneficial in treating barrier-disrupted skin disorders.